Drug Profile
Desonide gel - Ortho Dermatologics/LEO Pharma
Alternative Names: Desonate; Desonide hydrogelLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Dow Pharmaceutical Sciences; SkinMedica
- Developer LEO Pharma; Ortho Dermatologics
- Class Anti-inflammatories; Glucocorticoids; Pregnadienetriols; Small molecules
- Mechanism of Action Phospholipase A2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Atopic dermatitis
Most Recent Events
- 04 Sep 2018 Bayer transferred prescription dermatology business to LEO Pharma in the United States
- 27 Jul 2017 Valeant Pharmaceuticals International acquired Ortho Dermatologics in 2011 and changed the name of the later to Valeant Dermatology. Subsequently, in July 2017, it was rebranded to Ortho Dermatologics
- 19 Dec 2012 SkinMedica has been acquired by Allergan